Amended Loan Schedule to the Amended, Consolidated and Restated Secured Promissory Note dated November 10, 2022 issued to Abuse Deterrent Pharma, LLC on May 19, 2023 aggregating $3,469,279
Contract Categories:
Business Finance
- Loan Agreements
EX-10.70 5 acur-20211231xex10d70.htm EX-10.70
Exhibit 10.70
Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc and Abuse Deterrent Pharma, LLC
| Date |
| Principal |
| Aggregated |
| |||
| | | | | | ||||
Original Secured Promissory Note | | 11/10/2022 | | $ | 2,319,279 | | $ | 2,319,279 | |
Additional loans to be included: | | | | | | | |||
Loan #1 | | 12/22/2022 | | $ | 250,000 | | $ | 2,569,279 | |
Loan #2 | | 1/19/2023 | | $ | 250,000 | | $ | 2,819,279 | |
Loan #3 | | 2/22/2023 | | $ | 250,000 | | $ | 3,069,279 | |
Loan #4 | | 3/20/2023 | | $ | 250,000 | | $ | 3,319,279 | |
Loan #5 | | 5/19/2023 | | $ | 150,000 | | $ | 3,469,279 | |
